Sun Pharma Shares News

The share purchase will be for a cash consideration of MYR 2,861,365.65, Sun Pharma said.

The company had posted a net profit after taxes, share of profit/loss of associates, joint ventures and non-controlling interests of Rs 2,033.71 crore for the same period a year ago, Sun Pharmaceutical Industries said in a filing to the BSE.

Shares of Sun Pharma on Monday crashed by over 13 percent after the company reported a 14 percent decline in consolidated net profit for the fourth quarter ended March.

New Delhi: Drug major Sun Pharmaceutical Industries on Wednesday announced the launch of its sunscreen brand 'Suncros' through the company's Global Consumer Healthcare business vertical.

Shares of Sun Pharma rose by nearly 3 percent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for USD 293 million (over Rs 1,940 crore).

Sun Pharma had posted net profit after taxes and minority interest of Rs 1,204.59 crore for the April-June period of last fiscal, 2014-15.

Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.

Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.

Shares of Sun Pharmaceutical Industries plunged over 9 percent Monday, wiping out Rs 20,864 crore from its market valuation, after the company's fourth quarter earnings came below market expectations.

The stock plunged 11 percent to Rs 869.50 on the BSE. At the NSE, it dipped 10 percent to Rs 869.10.

Shares of Sun Pharmaceutical Wednesday recovered nearly 2 percent to close at Rs 967.15 on BSE a day after the stock took a severe beating following Daiichi Sankyo selling its entire 9 percent stake in the company for Rs 20,025 crore.

Stocks of Sun Pharmaceutical made a comeback at the bourses Wednesday, rising nearly 3 percent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore.

The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.

Shares of Sun Pharmaceutical on Tuesday plunged nearly 11 percent after Japan's Daiichi Sankyo announced selling its entire holding in the Indian drug major for an estimated Rs 20,420 crore.

Shares of Sun Pharmaceutical Industries Ltd slumped as much as 10.9 percent on Tuesday, heading towards their biggest daily fall since June 2009 after Japan`s Daiichi Sankyo Co Ltd started selling its stake in the Indian drugmaker.

Drugmaker Sun Pharma on Tuesday surpassed top lender SBI in terms of market capitalisation, becoming the eight most valued listed company in the country.

Shares of drug major Sun Pharma today fell by nearly 3 percent after the company reported 6.92 percent decline in consolidated net profit for the third quarter ended December 31, 2014-15.

Wind turbine maker Suzlon Energy has signed definitive agreements with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore.

Sun Pharma Managing Director Dilip Shanghvi's mother Kumud S Shanghvi, one of the promoters of Sun Pharma, has gifted nearly 31 lakh shares worth Rs 282 crore to her daughter-in-law Vibha D Shanghvi.

The NSE 50-share Nifty also slipped by 32.50 points, or 0.40 percent, to 8,061.60 after rising to 8,127.95 in early trade.